Development of Mass-Screening Method for the Identification of Patients at Risk of Developing Type 1 Diabetes Mellitus.
开发用于识别有患 1 型糖尿病风险的患者的大规模筛查方法。
基本信息
- 批准号:11672315
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The study on the development of mass-screening method for the identification of patients at risk of developing type 1 diabetes mellitus (DM) is described. The results are as follows.1. An ultrasensitive enzyme immunoassay (immune-complex transfer enzyme immunoassay) for IgA antibodies to cow's milk proteins has been developed, and the antibody levels in sera from patients with DM and healthy subjects were compared. However, no significant difference was observed. If anti-idiotype antibodies to the antibodies were present in serum, they might interfere with the assay, so suitable ELISA format was employed to minimize such interference. As results, the levels of IgA antibodies not only to the cow's milk proteins but also to an other food protein were significantly higher in former than latter.2. 50% of the patients had DQB1^*0401-DRB1^*0405 haplotype. In the patients with the haplotype, the levels of IgA antibodies to the cow's milk proteins, IgA and TGF-beta were significantly higher than those in the other patients. This was suggested that, in the digestive tract, an antigen presentation to Th3 was accelerated by the haplotype, subsequently, TGF-beta production was elevated, consequently, IgA antibody production was enhanced. Therefore, the IgA antibody response, that is, mucosal immune response, to the food antigen become a reliable marker for identification of patients at risk of developing DM.3. The assay method to assess the mucosal immune response to the cow's milk proteins using dried urine samples has been developed and validated. In addition, the levels of IgA antibodies in the dried urine samples and serum samples were correlated.In conclusion, the mass-screening method, in which the mucosal immune response to the cow's milk proteins is assessed by using the dried urine, can provide us with a reliable method for identification of patients at risk of developing DM.
本文介绍了一种鉴别1型糖尿病(DM)高危患者的大规模筛查方法的研究进展。结果如下:1。建立了一种针对牛奶蛋白的IgA抗体的超灵敏酶免疫测定法(免疫复合物转移酶免疫测定法),并比较了糖尿病患者和健康人血清中的抗体水平。然而,没有观察到显著差异。如果血清中存在针对抗体的抗独特型抗体,则可能干扰检测,因此采用合适的ELISA格式来减少这种干扰。结果表明,不仅针对牛奶蛋白的IgA抗体水平,而且针对其他一种食物蛋白的IgA抗体水平,前者明显高于后者。50%的患者为DQB1^*0401-DRB1^*0405单倍型。在单倍型患者中,针对牛奶蛋白、IgA和tgf - β的IgA抗体水平明显高于其他患者。这表明,在消化道中,单倍型加速了抗原向Th3的递呈,随后,tgf - β的产生升高,从而增强了IgA抗体的产生。因此,IgA抗体反应,即粘膜对食物抗原的免疫反应,成为鉴别患dm风险患者的可靠标志。已经开发并验证了使用干燥尿液样本评估粘膜对牛奶蛋白免疫反应的测定方法。此外,干燥尿液样本和血清样本中的IgA抗体水平存在相关性。综上所述,通过干燥的尿液来评估粘膜对牛奶蛋白的免疫反应的大规模筛查方法,可以为我们提供一种可靠的方法来识别有发展为糖尿病风险的患者。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeyuki Kohno et al: "Antivodies to food antigens in Japanese patients with type 1 diabetes mellitus."Diabetes Res.Clin.Prac.. (in press).
Takeyuki Kohno 等人:“日本 1 型糖尿病患者的食物抗原抗体。”糖尿病研究临床实践(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeyuki Kohno et al.: "Antibodies to food antigens in Japanese patients with type 1 diabetes mellitus."Diabetes Ras.Clin.Prac.. (in press).
Takeyuki Kohno 等人:“日本 1 型糖尿病患者的食物抗原抗体。”Diabetes Ras.Clin.Prac..(出版中)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takeyuki Kohno: "Antibodies to food antigens in Japanese patients with type1 diabetes mellitus."Diabetes Res.Clin.Prac.. (in press).
Takeyuki Kohno:“日本 1 型糖尿病患者的食物抗原抗体。”糖尿病研究临床实践(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOHNO Takeyuki其他文献
KOHNO Takeyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOHNO Takeyuki', 18)}}的其他基金
Development of methods for reducing venous pain caused by dacarbazine
开发减轻达卡巴嗪引起的静脉疼痛的方法
- 批准号:
15K08117 - 财政年份:2015
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel immunomodulator, FTY720, ameliorates spontaneous dermatitis in NC/Nga mice
一种新型免疫调节剂 FTY720 可改善 NC/Nga 小鼠的自发性皮炎
- 批准号:
19590166 - 财政年份:2007
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of ultra-sensitive enzyme immunoassay for anti-acetylcholine receptor autoantibody
抗乙酰胆碱受体自身抗体超灵敏酶联免疫分析方法的研制
- 批准号:
08672656 - 财政年份:1996
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Diabetes preventive function of cereal albumin considering gendered innovations
考虑性别创新的谷物白蛋白的糖尿病预防功能
- 批准号:
23K05099 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of albumin-binding fatty acid-modified nanoparticles for effective cancer therapy
开发用于有效癌症治疗的白蛋白结合脂肪酸修饰纳米颗粒
- 批准号:
23K06077 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of albumin pre-coating DLC coated artificial vascular graft
白蛋白预涂DLC涂层人工血管的研制
- 批准号:
23K08236 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CAREER: Developing albumin-binding responsive polypeptides for nucleic acid delivery
职业:开发用于核酸递送的白蛋白结合响应性多肽
- 批准号:
2238812 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Continuing Grant
ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial.
白蛋白促进严重急性肾损伤后的恢复 (ALTER-AKI):一项多中心随机对照试验。
- 批准号:
489100 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Operating Grants
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10522591 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10884052 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10611521 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
- 批准号:
10467737 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Albumin-binding nanocomplexes for delivery of combination siRNA therapeutics to KRAS-driven cholangiocarcinoma
白蛋白结合纳米复合物用于向 KRAS 驱动的胆管癌递送组合 siRNA 疗法
- 批准号:
10389971 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:














{{item.name}}会员




